CA Final · Financial Reporting · Ind AS 1 Presentation of Financial Statements
Kaveri Engineering Ltd's finance team notes that its auditor's Ind AS 1 checklist says an entity may adopt a 52-week reporting period, as is permitted under IAS 1. Kaveri's year-end would otherwise fall on a different weekday each year. How should Kaveri respond under Ind AS 1 as notified?
Kaveri cannot use a 52-week reporting period. IAS 1 allows such periodicity, but Ind AS 1 does not permit it, and the corresponding paragraph 37 content was deleted, with only the number retained to keep numbering consistent with IAS 1.
- AAdopt the 52-week period because Ind AS 1 retains the IAS 1 option
- BAdopt it only if the period varies by at most a few days from the year-end
- CAdopt it only with Board approval and disclosure
- DNot adopt it, because Ind AS 1 does not permit a 52-week periodicity and the related paragraph was deletedCorrect
Explanation
The comparison with IAS 1 states that IAS 1 permits a periodicity such as 52 weeks, but Ind AS 1 does not permit it and the text of paragraph 37 is deleted. Only the paragraph number is retained for consistency. Board approval or disclosure cannot restore a deleted option.
Did you get it right without looking?
One question tells you little. A timed set on Ind AS 1 Presentation of Financial Statements shows your real accuracy, how long you take and where you lose marks.
More Ind AS 1 Presentation of Financial Statements questions
- Narmada Foods Ltd approves its financial statements on 20 May. A non-adjusting event occurs on 25 May, before the shareholders' meeting. A d…
- Sunrise Textiles Ltd, an Indian company reporting under Ind AS, has always closed its books on the Saturday nearest 31 March, so its years r…
- Kaveri Pharma Ltd's draft Ind AS financial statements are titled 'Statement of Financial Position' and 'Statement of Profit or Loss and Othe…
- Meenakshi Foods Ltd's finance team is drafting its first Ind AS financial statements and wants to title the primary statements as 'Statement…
- Ganga Pharma Ltd acquired a business in a bargain purchase and, under Ind AS 103, recognised the gain directly in equity as capital reserve.…
- Bharat Pharma Ltd wants to present profit or loss in one statement and a separate, second statement beginning with profit or loss to show ot…